Trial Profile
Feasible strategy for preventing blood clots in critically ill patients with acute kidney Injury [Forebyggelse af Blodpropper hos patienter med akut nyresvigt pa Intensiv-afdeling]
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2013
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Therapeutic Use
- 07 Jan 2013 New trial record